» Articles » PMID: 34279931

Discovery of Selective Small-Molecule Inhibitors for the ENL YEATS Domain

Overview
Journal J Med Chem
Specialty Chemistry
Date 2021 Jul 19
PMID 34279931
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Eleven-nineteen leukemia (ENL) protein is a histone acetylation reader essential for disease maintenance in acute leukemias, in particular, the ()-rearranged leukemia. In this study, we carried out high-throughput screening of a small-molecule library to identify inhibitors for the ENL YEATS domain. Structure-activity relationship studies of the hits and structure-based inhibitor design led to two compounds, and , with IC values below 100 nM in inhibiting the ENL-acetyl-H3 interaction. Both compounds, and their precursor compound , displayed strong selectivity toward the ENL YEATS domain over all other human YEATS domains. Moreover, exhibited on-target inhibition of ENL in cultured cells and a synergistic effect with the bromodomain and extraterminal domain inhibitor JQ1 in killing leukemia cells. Together, we have developed selective chemical probes for the ENL YEATS domain, providing the basis for further medicinal chemistry-based optimization to advance both basic and translational research of ENL.

Citing Articles

A multivalent engagement of ENL with MOZ.

Becht D, Selvam K, Lachance C, Cote V, Li K, Nguyen M Nat Struct Mol Biol. 2025; .

PMID: 39794553 DOI: 10.1038/s41594-024-01455-8.


Crotonylation modification and its role in diseases.

Guo Y, Li J, Zhang K Front Mol Biosci. 2024; 11:1492212.

PMID: 39606030 PMC: 11599741. DOI: 10.3389/fmolb.2024.1492212.


Targeting lysine acetylation readers and writers.

Zhou M, Cole P Nat Rev Drug Discov. 2024; 24(2):112-133.

PMID: 39572658 PMC: 11798720. DOI: 10.1038/s41573-024-01080-6.


Prioritization of Eleven-Nineteen-Leukemia Inhibitors as Orally Available Drug Candidates for Acute Myeloid Leukemia.

Guo X, Atla S, Nyalata S, Alugubelli Y, Chen P, Xu S J Med Chem. 2024; 67(22):20100-20117.

PMID: 39530508 PMC: 11613437. DOI: 10.1021/acs.jmedchem.4c01337.


MLL oncoprotein levels influence leukemia lineage identities.

Janssens D, Duran M, Otto D, Wu W, Xu Y, Kirkey D Nat Commun. 2024; 15(1):9341.

PMID: 39472576 PMC: 11522475. DOI: 10.1038/s41467-024-53399-8.


References
1.
Zimmermann K, Ahrens K, Matthes S, Buerstedde J, Stratling W, Phi-van L . Targeted disruption of the GAS41 gene encoding a putative transcription factor indicates that GAS41 is essential for cell viability. J Biol Chem. 2002; 277(21):18626-31. DOI: 10.1074/jbc.M200572200. View

2.
Wan L, Wen H, Li Y, Lyu J, Xi Y, Hoshii T . ENL links histone acetylation to oncogenic gene expression in acute myeloid leukaemia. Nature. 2017; 543(7644):265-269. PMC: 5372383. DOI: 10.1038/nature21687. View

3.
Hsu C, Shi J, Yuan C, Zhao D, Jiang S, Lyu J . Recognition of histone acetylation by the GAS41 YEATS domain promotes H2A.Z deposition in non-small cell lung cancer. Genes Dev. 2018; 32(1):58-69. PMC: 5828395. DOI: 10.1101/gad.303784.117. View

4.
Jenuwein T, Allis C . Translating the histone code. Science. 2001; 293(5532):1074-80. DOI: 10.1126/science.1063127. View

5.
Li Y, Wen H, Xi Y, Tanaka K, Wang H, Peng D . AF9 YEATS domain links histone acetylation to DOT1L-mediated H3K79 methylation. Cell. 2014; 159(3):558-71. PMC: 4344132. DOI: 10.1016/j.cell.2014.09.049. View